EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Treatment of single gingival recessions using iPRF‐biofunctionalized collagen matrix: A randomized clinical trial

Mauro Pedrine Santamaria iD, Amanda Rossato iD, Manuela Maria Viana Miguel iD, Ana Carolina Ferreira Bonafé iD, Ingrid Fernandes Mathias-Santamaria iD, Marcelo Pereira Nunes iD

Journal of Periodontology · 04.06.2026

DOI: 10.1002/jper.70152 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Periodontology, online erschienen am 04.06.2026. Verfasst von Mauro Pedrine Santamaria und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Dentistry, University of Kentucky, Lexington, Kentucky, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: NIH National Center for Advancing Translational Sciences, Geistlich Pharma AG, Coordination for the Improvement of Higher Education Personnel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The biofunctionalization of collagen matrices (CMs) with injectable platelet‐rich fibrin (i‐PRF) has been proposed to enhance their bioactivity and clinical efficacy in the treatment of gingival recessions (GRs). This study evaluated the use of a volume‐stable collagen matrix (VCMX) biofunctionalized with i‐PRF as an adjunct to the coronally advanced flap (CAF) for single GRs.

Methods

Seventy‐five patients with single RT1 GR were randomly assigned to CAF, CAF+VCMX, or CAF+VCMX+iPRF. Clinical, esthetic, and patient‐centered outcomes were assessed at baseline and at 6 months.

Results

All groups resulted in significant recession reduction (CAF: 1.93 ± 0.86 mm; CAF+VCMX: 1.64 ± 0.68 mm; CAF+VCMX+iPRF: 1.70 ± 0.84 mm), with no statistically significant differences among groups ( p = 0.36). Groups treated with VCMX showed greater gingival thickness (GT) gain (CAF: 0.18 ± 0.25 mm; CAF+VCMX: 0.39 ± 0.26 mm; CAF+VCMX+iPRF: 0.45 ± 0.29 mm), favoring CAF+VCMX+iPRF ( p < 0.001). No significant keratinized tissue width (KTW) gain was observed ( p > 0.05). Adjusted models identified baseline KTW and KTW gain as positive predictors of complete root coverage (CRC), and KTW gain as the main predictor for RecRed and %RC.

Conclusions

All approaches were effective in reducing GR and improving clinical parameters. The iPRF addition to the VCMX may not improve root coverage outcomes (NCT05916742). Plain language summary Gingival recession, or receding gums, occurs when the gum moves away from the tooth, exposing the root of the tooth. This can cause sensitivity and esthetic concerns and increase the tooth's susceptibility to problems. A common surgical treatment is the coronally advanced flap (CAF), which repositions the gum to cover the exposed root. In some cases, dentists add a collagen matrix to help thicken the gum and to improve the outcome. A newer option enhances this matrix with a patient's own blood product called injectable platelet‐rich fibrin (i‐PRF), which may improve healing. This study included 75 patients with a single recession defect. They were randomly assigned to one of three treatments: CAF alone, CAF with a collagen matrix, or CAF with a collagen matrix enhanced with i‐PRF. After 6 months, all treatments led to similar improvements in root coverage, sensitivity, and esthetics. However, patients who received the collagen matrix, especially when combined with i‐PRF, developed thicker gum tissue. Thicker and wider gum tissue is associated with better long‐term outcomes. All procedures were well tolerated and caused minimal discomfort. Overall, adding a collagen matrix, particularly when enhanced with i‐PRF, may support thicker gums and help to maintain long‐term results.

Schlagwörter

Stichwörter der Autor:innen

dental estheticsgingival recessiontissue engineeringtissue scaffoldstooth cervix

Autor:innen und Institutionen

  • College of Dentistry, University of Kentucky, Lexington, Kentucky, USA.
  • Division of Periodontics, Institute of Science and Technology, São Paulo State University (Unesp), São José dos Campos, São Paulo, Brazil.
  • Instituto Proimperio (private practice), São Paulo, São Paulo, Brazil.

ORCID-Profile: Mauro Pedrine Santamaria, Amanda Rossato, Manuela Maria Viana Miguel, Ana Carolina Ferreira Bonafé, Ingrid Fernandes Mathias-Santamaria, Marcelo Pereira Nunes

Förderung

  • NIH National Center for Advancing Translational Sciences
  • Geistlich Pharma AG
  • Coordination for the Improvement of Higher Education Personnel
  • Research Funding Agency of São Paulo State (FAPESP)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Santamaria, M. P., Rossato, A., Miguel, M. M. V., Bonafé, A. C. F., Mathias-Santamaria, I. F., & Nunes, M. P. (2026). Treatment of single gingival recessions using iPRF‐biofunctionalized collagen matrix: A randomized clinical trial. Journal of Periodontology. https://doi.org/10.1002/jper.70152

Vancouver

Santamaria MP, Rossato A, Miguel MMV, Bonafé ACF, Mathias-Santamaria IF, Nunes MP. Treatment of single gingival recessions using iPRF‐biofunctionalized collagen matrix: A randomized clinical trial. Journal of Periodontology. 2026. doi:10.1002/jper.70152

BibTeX
@article{Santamaria2026,
  author = {Santamaria, Mauro Pedrine and Rossato, Amanda and Miguel, Manuela Maria Viana and Bonafé, Ana Carolina Ferreira and Mathias-Santamaria, Ingrid Fernandes and Nunes, Marcelo Pereira},
  title = {Treatment of single gingival recessions using iPRF‐biofunctionalized collagen matrix: A randomized clinical trial},
  journal = {Journal of Periodontology},
  year = {2026},
  doi = {10.1002/jper.70152}
}
Kostenlos starten →